CTRI/2023/05/052174进行中（未招募）Unknown
Efficacy of Vilanterol- Fluticasone Furoate versus Formoterol-Budesonide combination therapy in stable asthma
Department of Pulmonary, Critical Care and sleep Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Stable asthma patients on formoterol-budesonide combination with following eligibility criteria:
- •1. >18 years of age
- •2. On Formoterol- budesonide therapy for atleast >12 weeks prior to enrollment
排除标准
- •¬Uncontrolled asthma patient (ACT score <15)
- •¬Severe refractory asthma
- •¬Patients with history of acute exacerbation of Asthma in the preceding 6 weeks
- •¬Patient with known or suspected allergy to VI-FF
- •¬Asthma patients with other respiratory co-morbidities like COPD, lung cancer and interstitial lung disease.
- •Patients who are not able to perform spirometry
研究者
相似试验
尚未招募
3 期
A comparison of vilanterol/Fluticasone furoate with Formoterol/Budesonide in the management of bronchial asthmaCTRI/2024/03/064848SRM College of Pharmacy
已完成
1 期
Relovair PD PK in Chinese Healthy SubjectsAsthmaNCT01711463GlaxoSmithKline16
已完成
不适用
Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimeRespiratory disease requiring bronchoscopyJPRN-UMIN000017645Gifu Municipal Hospital20
已完成
3 期
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsAsthmaNCT01147848GlaxoSmithKline810
撤回
4 期
The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on AsthmaAsthmaNCT03363191GlaxoSmithKline